Cargando…
Oroxin B Attenuates Ovariectomy-Induced Bone Loss by Suppressing Osteoclast Formation and Activity
BACKGROUND: Osteoclasts are the major players in bone resorption and have always been studied in the prevention and treatment of osteoporosis. Previous studies have confirmed that a variety of flavonoids inhibit osteoporosis and improve bone health mainly through inhibiting osteoclastogenesis. Oroxi...
Autores principales: | Huang, Jun-ming, Wang, Chen-zhong, Lu, Shun-yi, Wang, Zhe, Yan, Zuo-qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643139/ https://www.ncbi.nlm.nih.gov/pubmed/34876805 http://dx.doi.org/10.2147/DDDT.S328238 |
Ejemplares similares
-
Isoliensinine Suppresses Osteoclast Formation Through NF-κB Signaling Pathways and Relieves Ovariectomy-Induced Bone Loss
por: Liu, Huijiang, et al.
Publicado: (2022) -
Protective Effect of Ciclopirox against Ovariectomy-Induced Bone Loss in Mice by Suppressing Osteoclast Formation and Function
por: Ihn, Hye Jung, et al.
Publicado: (2021) -
Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss
por: Xiong, Jinhu, et al.
Publicado: (2018) -
Host–guest interaction of cucurbit[8]uril with oroxin A and its effect on the properties of oroxin A
por: Zeng, Zhishu, et al.
Publicado: (2020) -
Sphingosylphosphorylcholine blocks ovariectomy‐induced bone loss by suppressing Ca(2+)/calmodulin‐mediated osteoclast differentiation
por: Lee, Ha Young, et al.
Publicado: (2020)